TITLE

Renal cell carcinoma and chronic lymphocytic leukemia

AUTHOR(S)
Sargin, Gokhan; Yavasoglu, Irfan
PUB. DATE
June 2013
SOURCE
Medical Oncology;Jun2013, Vol. 30 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
87820153

 

Related Articles

  • Small Cell Undifferentiated Carcinoma of the Colon Associated With Chronic Lymphocytic Leukemia. Yamaguchi, Sayuri; Sawamura, Morio; Murakami, Hirokazu // American Journal of Gastroenterology;May1993, Vol. 88 Issue 5, p795 

    Presents a letter to the editor on the association of small cell undifferentiated carcinoma of the colon with chronic lymphocytic leukemia.

  • Voriconazole.  // Reactions Weekly;Jul2015, Vol. 1560 Issue 1, p159 

    An abstract of the article "Voriconazole-induced multiple squamous cell carcinomas in a patient with chronic lymphocytic leukemia," by V. A. Patel and colleagues is presented.

  • Metastatic Renal Cell Carcinoma to the Parotid Gland in the Setting of Chronic Lymphocytic Leukemia. Deeb, Robert; Ziying Zhang; Ghanem, Tamer // Case Reports in Medicine;2012, p1 

    Renal cell carcinoma (RCC) is infamous for its unpredictable behavior and metastatic potential. We report a case of a patient with a complex history of multifocal renal cell carcinoma and chronic lymphocytic leukemia (CLL), who subsequently developed a parotid mass. Total parotidectomy revealed...

  • Oncology Update. Smart, Michael // Oncology Nursing Forum;Mar2010, Vol. 37 Issue 2, p223 

    The article presents information on the approval of new drugs by the U.S. Food & Drug Administration (FDA). The oral multityrosine kinase inhibitor pazopanib for the treatment of advanced renal cell carcinoma and ofatumumab used for the treatment of chronic lymphocytic leukemia and produced by...

  • Hodgkin's disease type Richter's syndrome in chronic lymphocytic leukemia. Juneja, S; Carney, D; Ellis, D; Januszewicz, E H; Wolf, M; Prince, H M // Leukemia (08876924);May99, Vol. 13 Issue 5, p826 

    Presents a letter to the editor on chronic lymphocytic leukemia, published in May 1999 issue of the journal 'Leukemia'. Details of chronic lymphocytic leukemia transformations to large cell lymphoma; Occurrence of large cell transformations; Risks involved with Hodgkin's diseases.

  • Bright Grey extends critical-illness cancer protection. Thomas, Paul // Mortgage Strategy (Online Edition);6/5/2013, p40 

    The article discusses the extension in the critical-illness cancer definition of protection provider Bright Grey for its personal and business protection plans which now have additional cover for chronic lymphocytic leukemia, basal cell carcinoma, and squamous cell carcinoma.

  • The prognostic impact of minimal residual disease assessment after stem cell transplantation for chronic lymphocytic leukemia: is achievement of molecular remission worthwhile? Dreger, P.; Ritgen, M.; Böttcher, S.; Schmitz, N.; Kneba, M. // Leukemia (08876924);Jul2005, Vol. 19 Issue 7, p1135 

    Comments on the prognostic impact of minimal residual disease assessment after stem cell transplantation on chronic lymphocytic leukemia. Methods of detecting and measuring chronic lymphocytic leukemia cells; Measurement of minimal residual chronic lymphocytic leukemia disease; Treatment...

  • Oncology today: Leukemia. Medoff, Erin; Moore, Kathleen // RN;Sep2000, Vol. 63 Issue 9, p42 

    Reports on advances in the treatment of leukemia. Signs and symptoms; Acute myelogenous leukemia; Acute lymphocytic leukemia; Chronic myelogenous leukemia; Chronic lymphocytic leukemia; All-trans-retinoic acid; Stem cell transplantation; Haploidentical stem cell transplantation.

  • CLL: Therapy.  // Hematology Journal;2004 Supplement 2, Vol. 5, pS26 

    Presents abstracts of studies on chronic lymphocytic leukemia (CLL) therapy. Alemtuzumab (Campath, Mabcampath) consolidation after fludarabine phosphate and cyclophosphamide second-line chemotherapy for progressive chronic lymphocytic leukemia; Immunotherapy of B-cell chronic lymphocytic...

  • Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral blood. Bhattacharya, N.; Diener, S.; Idler, I. S.; Barth, T. F.; Rauen, J.; Habermann, A.; Zenz, T.; Möller, P.; Döhner, H.; Stilgenbauer, S.; Mertens, D. // Leukemia (08876924);Apr2011, Vol. 25 Issue 4, p722 

    A letter to the editor is presented that focuses on a study on the phenotype of non-malignant B cells and chronic lymphocytic leukemia cells.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics